1. Home
  2. LLYVK vs STVN Comparison

LLYVK vs STVN Comparison

Compare LLYVK & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LLYVK

Liberty Media Corporation

N/A

Current Price

$94.85

Market Cap

8.6B

Sector

Industrials

ML Signal

N/A

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

N/A

Current Price

$14.76

Market Cap

4.2B

ML Signal

N/A

Company Overview

Basic Information
Metric
LLYVK
STVN
Founded
1991
1949
Country
United States
Italy
Employees
N/A
N/A
Industry
Broadcasting
Containers/Packaging
Sector
Industrials
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.6B
4.2B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
LLYVK
STVN
Price
$94.85
$14.76
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$25.13
AVG Volume (30 Days)
339.4K
574.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
0.41%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$10.26
Revenue Next Year
$9.89
$10.02
P/E Ratio
N/A
$27.15
Revenue Growth
N/A
N/A
52 Week Low
$60.55
$13.91
52 Week High
$102.14
$28.00

Technical Indicators

Market Signals
Indicator
LLYVK
STVN
Relative Strength Index (RSI) 52.58 40.93
Support Level $94.62 $14.03
Resistance Level $101.92 $17.14
Average True Range (ATR) 3.44 0.88
MACD -0.41 0.05
Stochastic Oscillator 22.20 16.11

Price Performance

Historical Comparison
LLYVK
STVN

About LLYVK Liberty Media Corporation

Liberty Live Holdings Inc focuses on live entertainment investments. The company maintains a substantial ownership position in Live Nation Entertainment, the primary international promoter of concerts, events, and ticketing through platforms like Ticketmaster, alongside sponsorship and hospitality services via QuintEvents.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

Share on Social Networks: